Your browser doesn't support javascript.
loading
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Yu, Evan Y; Piulats, Josep M; Gravis, Gwenaelle; Fong, Peter C C; Todenhöfer, Tilman; Laguerre, Brigitte; Arranz, Jose A; Oudard, Stephane; Massard, Christophe; Heinzelbecker, Julia; Nordquist, Luke T; Carles, Joan; Kolinsky, Michael P; Augustin, Marinela; Gurney, Howard; Tafreshi, Ali; Li, Xin Tong; Qiu, Ping; Poehlein, Christian H; Schloss, Charles; de Bono, Johann S.
Affiliation
  • Yu EY; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: evanyu@u.washington.edu.
  • Piulats JM; Catalan Institute of Oncology, Barcelona, Spain.
  • Gravis G; Institut Paoli Calmettes, Marseille, France.
  • Fong PCC; Auckland City Hospital, Auckland, New Zealand; University of Auckland, Auckland, New Zealand.
  • Todenhöfer T; Studienpraxis Urologie, Nürtingen, Germany.
  • Laguerre B; Centre Eugène Marquis, Rennes, France.
  • Arranz JA; General University Hospital Gregorio Marañón, Madrid, Spain.
  • Oudard S; Hôpital Européen Georges Pompidou, University of Paris, Paris, France.
  • Massard C; Gustave Roussy, Cancer Campus, Villejuif, France; Paris-Saclay University, Villejuif, France.
  • Heinzelbecker J; Saarland University Medical Center, Homburg, Germany; Faculty of Medicine, Saarland University, Homburg, Germany.
  • Nordquist LT; GU Research Network-Urology Cancer Center, Omaha, NE, USA.
  • Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron, Barcelona, Spain.
  • Kolinsky MP; Cross Cancer Institute and University of Alberta, Edmonton, AB, Canada.
  • Augustin M; Paracelsus Medical University, Nuremberg, Germany.
  • Gurney H; Macquarie University, Sydney, Australia.
  • Tafreshi A; University of Wollongong, Wollongong, NSW, Australia.
  • Li XT; Merck & Co., Inc., Rahway, NJ, USA.
  • Qiu P; Merck & Co., Inc., Rahway, NJ, USA.
  • Poehlein CH; Merck & Co., Inc., Rahway, NJ, USA.
  • Schloss C; Merck & Co., Inc., Rahway, NJ, USA.
  • de Bono JS; The Institute of Cancer Research and the Royal Marsden, London, UK.
Eur Urol ; 83(1): 15-26, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36055895
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Etiology_studies Limits: Aged / Humans / Male Language: En Journal: Eur Urol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Etiology_studies Limits: Aged / Humans / Male Language: En Journal: Eur Urol Year: 2023 Type: Article